Gait speed and grip strength decline faster in persons with HIV (PWH) compared to those without HIV. Abnormal glucose metabolism has been associated with impaired physical function in cross-sectional studies. We evaluated longitudinal relationships between hyperglycemia and objective measures of physical function in men with and without HIV.
The Multicenter AIDS Cohort Study (MACS) is a prospective study of men with or at risk for HIV. MACS participants undergo semi-annual assessments, including measures of glycemic status (fasting blood glucose and hemoglobin A1C (HbA1C)), grip strength and gait speed. Glycemic status was categorized as normal, impaired fasting glucose (IFG), controlled diabetes mellitus ((DM) (HbA1C <7.5%)) or uncontrolled DM (HbA1C >7.5%). Linear mixed models with random intercept were used to assess associations between glycemic status, gait speed and grip strength between 2006-2018.
Of 2,575 men, 54% were PWH. Mean age at baseline was 45.0 years among PWH and 49.2 years among men without HIV. At baseline, DM was more common among men with vs without HIV (p <0.05) and PWH had slower gait speed (p=0.001) but not reduced grip strength compared to seronegative controls. In multivariate models including all participants, HIV serostatus was not significantly associated with change in gait speed or grip strength (all p>0.05). Compared to men with normal glucose, those with controlled DM had greater gait speed decline (-0.015 m/s [-0.028, -0.001], p=0.03) and those with uncontrolled diabetes had greater grip strength decline (-0.877 kg [-1.623, -0.130], p=0.021) regardless of serostatus. In multivariate models restricted to PWH, neither IFG nor DM had significant effects on gait speed, but uncontrolled DM was associated with significantly greater decline in grip strength (-1.818 kg [-2.868, -0.767]; p=0.001), with a larger effect among men with HIV vs all participants (-1.818 vs -0.877 kg).
Abnormal glucose metabolism was associated with declines in gait speed and grip strength regardless of HIV serostatus, with uncontrolled DM exerting a greater effect on grip strength decline among PWH. These data suggest that improved glucose control, independent of virologic suppression, is an intervenable target to prevent progression of physical function limitations among PWH.